COMMUNIQUÉS West-GlobeNewswire

Spero Therapeutics Announces $5.9 Million Award from U.S. Department of Defense to Further Clinical Development of SPR206
16/07/2019
CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
Trefoil Therapeutics Raises $28 Million Series A to Advance Engineered FGF-1 for the Treatment of Corneal Diseases
16/07/2019
Lead candidate TTHX1114 will advance to IND and clinical study in corneal endothelial disease in early 2020 SAN DIEGO, July 16, 2019 (GLOBE NEWSWIRE) -- Trefoil Therapeutics announced it raised $28 million in an [...]
Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update
16/07/2019
~ Expects to Report Second Quarter 2019 Net Product Sales of Approximately $13.8 Million, Which Represents an Increase of 17 Percent Over the First Quarter of 2019 ~ ~ Anticipates Having Approximately $90 Million of [...]
Immunotherapy Company Enlivex Announces Dual Listing on the Tel-Aviv Stock Exchange
16/07/2019
The Company's shares, which currently trade on NASDAQ , will be dual-listed on the Tel Aviv Stock Exchange (TASE) starting on July 22, 2019, under the symbol ENLV Tel-Aviv, Israel, July 16, 2019 (GLOBE NEWSWIRE) -- [...]
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
16/07/2019
OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No. 15/666,057, which covers [...]
Aptose Doses First CLL Patient in Phase 1 Study of CG-806 and Doses Third Cohort in Phase 1 Study of APTO-253
16/07/2019
– CG-806 oral non-covalent pan-FLT3/pan-BTK inhibitor being developed for the treatment of CLL and other B-cell malignancies and for AML – – APTO-253 MYC inhibitor being developed for the treatment of AML and MDS – SAN [...]
hATTR Compass™ Genetic Testing Program Continues to Expand and Enable Diagnosis and Treatment of Hereditary ATTR Amyloidosis One Year Following Launch
16/07/2019
Akcea and Ambry Genetics grow partnership, providing easily accessible, no-cost, confidential genetic testing and genetic counseling services to people with suspected hereditary ATTR amyloidosis BOSTON and Aliso Viejo, [...]
Notable Announces $40M Series B Round to Fuel Development of Its Drug Discovery Platform for Personalized Oncology
16/07/2019
B Capital Group and LifeForce Capital Co-Lead Investment to Accelerate Notable’s Automated Lab, AI Technology, and Precision Drug Discovery SAN FRANCISCO, July 16, 2019 (GLOBE NEWSWIRE) -- Notable , which is redefining [...]
IRADIMED CORPORATION to Hold 2019 Second Quarter Financial Results Conference Call on July 30th
16/07/2019
WINTER SPRINGS, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market opens on Tuesday, [...]
Kymab Appoints Catherine Moukheibir as Non-Executive Director
16/07/2019
Kymab Appoints Catherine Moukheibir as Non-Executive Director Cambridge, UK; July 16, 2019 : Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics, announces the appointment of [...]
Inivata Signs Distribution Agreement with IPS Genomix for InVision® Genomic Tests in the Middle East and Africa
16/07/2019
Inivata Signs Distribution Agreement with IPS Genomix for InVision ® Genomic Tests in the Middle East and Africa Research Triangle Park, NC, USA and Cambridge, UK, and Dubai, UAE , July 16, 2019 -- Inivata , a leader in [...]
YSS Corp. Announces Receipt of Eleventh Retail Cannabis Store License
16/07/2019
CALGARY, Alberta, July 16, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce the receipt of an additional cannabis retail license from the Alberta Gaming, [...]
Atara Biotherapeutics Announces Plan to Initiate Tab-cel® FDA Biologics License Application Submission Next Year
16/07/2019
SOUTH SAN FRANCISCO, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Kane Biotech Announces New Agreement with FreeMind Group
16/07/2019
WINNIPEG, Manitoba, July 16, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2019
16/07/2019
Company Announcement Net sales of DARZALEX ® in the second quarter of 2019 totaled USD 774 million Genmab will receive royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen, Denmark; July 16, 2019 – Genmab [...]
Exactus Inc. Announces Appointment of New Chief Financial Officer
16/07/2019
Seasoned, Strategic Finance Executive Kenneth E. Puzder Joins Exactus Senior Management Team DELRAY BEACH, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) – (the “Company”), a healthcare company [...]
CorVel Announces Quarterly Earnings Release Webcast
16/07/2019
IRVINE, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Michael Combs, President and Chief Executive Officer Brandon O’Brien, Chief Financial Officer Date: Tuesday July 30, [...]
Immuron North American revenue surges by 52% in FY19
16/07/2019
Key Highlights: Immuron FY19 revenue surged by 52% in North America, reaching $1.16M. In the USA, FY19 Travelan® sales exceeded the $1M AUD milestone for the first time and grew by +32% to $1.02M AUD. In May 2019, USA [...]
ROSINBOMB Announces Their Patent Pending Flow Channel Technology™ Enabling Mass Production of Solventless Oils and Extracts
16/07/2019
Revolutionary Technology Poised to Disrupt the Multibillion Dollar Extract Market RENO, Nev., July 16, 2019 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC:MVRK), manufacturer of the highly acclaimed ROSINBOMB™ [...]

Pages